T cells, graft-versus-host disease and graft-versus-leukemia: Innovative approaches for blood and marrow transplantation

被引:0
|
作者
Champlin, R
Giralt, S
Gajewski, J
机构
关键词
bone marrow transplantation; graft-versus-host disease; graft-versus-leukemia; CHRONIC MYELOGENOUS LEUKEMIA; DEPLETED BONE-MARROW; SEVERE COMBINED IMMUNODEFICIENCY; LYMPHOCYTES-T; CYTOKINE DYSREGULATION; SELECTIVE DEPLETION; UNRELATED DONORS; SUBSETS; ENGRAFTMENT; PREVENTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allogeneic bone marrow transplantation is most commonly used as treatment for leukemia. Allotransplantation is associated with several interrelated immunologic processes, graft rejection, graft-versus-host disease (GvHD) and graft versus leukemia (GvL). Graft rejection can be overcome by intensive pretransplant immunosuppressive therapy. Following transplantation, immunoreconstitution must occur from donor-derived progenitors and GvHD may occur from reactivity of donor-derived immunocompetent cells against host tissues. In a related, but distinct process, donor immunocompetent cells may react against the recipient leukemia and recent data confirm that this GvL effect plays a critical role in preventing posttransplant relapse. This report summarizes present data regarding the mechanism of these processes. A major challenge is to separate the beneficial GvL effect from GvHD, the major complication of allogeneic marrow transplantation. We summarize data regarding innovative approaches to modify the composition of the transplanted marrow to optimize clinical outcome as well as use of donor lymphocyte infusions as a means to induce posttransplant GvL.
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [1] Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation
    Cao, Jiang
    Chen, Chong
    Zeng, Lingyu
    Li, Li
    Li, Zhenyu
    Xu, Kailin
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1374 - 1382
  • [2] Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia Activity
    Zhao, Shuting
    Zhang, Lingling
    Han, Jianfeng
    Chu, Jianhong
    Wang, Hai
    Chen, Xilin
    Wang, Youwei
    Tun, Norm
    Lu, Lanchun
    Bai, Xue-Feng
    Yearsley, Martha
    Devine, Steven
    He, Xiaoming
    Yu, Jianhua
    ACS NANO, 2016, 10 (06) : 6189 - 6200
  • [3] Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
    Li, Jian-Ming
    Giver, Cynthia R.
    Lu, Ying
    Hossain, Mohammad S.
    Akhtari, Mojtaba
    Waller, Edmund K.
    IMMUNOTHERAPY, 2009, 1 (04) : 599 - 621
  • [4] Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity
    Stenger, Elizabeth O.
    Turnquist, Heth R.
    Mapara, Markus Y.
    Thomson, Angus W.
    BLOOD, 2012, 119 (22) : 5088 - 5103
  • [5] GRAFT-VERSUS-LEUKEMIA ACTIVITY AFTER BONE-MARROW TRANSPLANTATION DOES NOT REQUIRE GRAFT-VERSUS-HOST DISEASE
    GLASS, B
    UHAREK, L
    GASSMANN, W
    FOCKS, B
    BOLOURI, H
    LOEFFLER, H
    MUELLERRUCHHOLTZ, W
    ANNALS OF HEMATOLOGY, 1992, 64 (06) : 255 - 259
  • [6] Temporal discordance between graft-versus-leukemia and graft-versus-host responses: A strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity?
    Hari, P
    Logan, B
    Drobyski, WR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (11) : 743 - 747
  • [7] Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
    Sprangers, Ben
    Fevery, Sabine
    Van Wijmeersch, Bart
    De Somer, Lien
    Waer, Mark
    Billiau, An D.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4568 - 4594
  • [8] Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect
    Alyea, Edwin P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (02) : 239 - 250
  • [9] Human Mesenchymal Stromal Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia Activity Following Experimental Allogeneic Bone Marrow Transplantation
    Auletta, Jeffery J.
    Eid, Saada K.
    Wuttisarnwattana, Patiwet
    Silva, Ines
    Metheny, Leland
    Keller, Matthew D.
    Guardia-Wolff, Rocio
    Liu, Chen
    Wang, Fangjing
    Bowen, Theodore
    Lee, Zhenghong
    Solchaga, Luis A.
    Ganguly, Sudipto
    Tyler, Megan
    Wilson, David L.
    Cooke, Kenneth R.
    STEM CELLS, 2015, 33 (02) : 601 - 614
  • [10] Kras-Deficient T Cells Attenuate Graft-versus-Host Disease but Retain Graft-versus-Leukemia Activity
    Luo, Lan
    Chen, Yuhong
    Chen, Xiao
    Zheng, Yongwei
    Zhou, Vivian
    Yu, Mei
    Burns, Robert
    Zhu, Wen
    Fu, Guoping
    Felix, Juan C.
    Hartley, Christopher
    Damnernsawad, Alisa
    Zhang, Jing
    Wen, Renren
    Drobyski, Williams R.
    Gao, Chunji
    Wang, Demin
    JOURNAL OF IMMUNOLOGY, 2020, 205 (12): : 3480 - 3490